Trial Profile
A Study to Evaluate the Efficacy and Safety of Sorafenib in Patients with Hepatocellular Carcinoma (HCC)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Dec 2015
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer
- Focus Adverse reactions; Therapeutic Use
- 15 Dec 2015 New trial record